Ian Carroll, PhD

​

Assistant Professor

Division of Gastroenterology and Hepatology,

Center for Gastrointestinal Biology and Disease (CGIBD),

Chapel Hill, North Carolina

​

​

The goals of the Carroll Lab are to determine the mechanisms through which the intestinal microbiota or its metabolites influence gastrointestinal physiology, behavior and adiposity/weight regulation with a view to developing novel nutritional-based therapies for disease. 

Dr. Carroll's laboratory uses molecular techniques to characterize the intestinal microbiota in both human and mouse models of nutritional-based diseases. Our investigations ultimately will contribute to understanding host-microbe interactions, where the knowledge gained can be applied to enhance health and reduce illness.

​

Speaker Disclosure Statement:

Ian Carroll, PhD, has disclosed that he has served as a consultant for Salix Pharmaceuticals and Vivelix, he has a collaboration with OpenBiome.